HR Execs on the Move

Igentify

www.igentify.com

 
Igentify® is a digital health company. We help clinicians, laboratories, and patients access, interpret, and use genetic information and education more effectively. Igentify developed the world`s first Digital Genetic Assistant, a software-based decision support platform. Our platform is capable of providing a fully scalable end-to-end genetic counseling solution in both clinical as well as non-clinical (direct-to-consumer) genetic testing set up. The platform is built for various genotyping technologies like microarray and next-generation sequencing (NGS). It can be customized to a broad spectrum of genetic and genomic tests offered by the test providers. Founded in Oct. 2016, Igentify`s team of globally ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.igentify.com
  • 7 World Trade Center, 250 Greenwich Street
    New York, NY USA 10007
  • Phone: 888.353.8679

Executives

Name Title Contact Details
Danielle Gutter
 Vice President of Global Sales Profile
Amanda Swiatocha
 Vice President of Marketing Profile

Similar Companies

Barber Optics Inc

Barber Optics Inc is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Budget Medical Equipment-Supl

Budget Medical Equipment-Supl is a Port Charlotte, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

United BioSource Corporation

United BioSource Corporation is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.

Heritage of Edina Inc

Heritage of Edina Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.